Abstract:FGF-21 is a new member of FGF family and reported to regulate glucose metabolism, as well as lipid homeostasis, therefore, FGF-21 is a potential therapeutics for treatment of diabetes and metabolic syndrome. However, little is known about its functional receptor(s) and mechanism of action. The aim of the paper is to investigate the functional receptor(s) for FGF-21 in order to understand the mechanism of action of the molecule. Previous result showed that FGF-21 could stimulate glucose uptake in differentiated 3T3L1 adipocytes, but not in pre-adipocytes, suggesting that differentiated 3T3L1 adipocytes express functional receptor (s) for FGF-21. Therefore, the differentiated 3T3L1 adipocyte is a perfect target for searching receptor (s) of FGF-21. 3T3L1 pre-adipocytes were differentiated into adipocytes. The cell membrane of the life adipocytes were incubated with FGF-21 which was labeled with either Flag-tag or biotin, the FGF-21/receptor complexes were cross-linked once they interacted by cross-link reagent BS3. The FGF-21/receptor complexes were immunoprecipitated by either Flag antibody or streptavidin and analyzed by SDS-PAGE. The results showed that FGF-21 could form putative FGF-21/receptor (s) complexes with surface membrane protein of differentiated 3T3L1 adipocytes, not pre-adipocytes. The molecular mass of the complexes is proximate 300 similar to 400 ku. The complexes were formed by the FGF-21 labeled with either Flag-tag or biotin, suggesting the complex formation was not influenced by different labeling. To understand the component of the FGF-21/receptor(s) complexes, Western blot assay was used to examine the interaction of the complexes with known antibodies. FGFR-2 was detected within the FGF-21/receptor complexes by specific antibody for FGFR-2. To confirm the specific relationship between FGF-21 and FGFR-2, FGF-21-induced FGFR-2 tyrosine-phosphorylation was studied in 3T3L1 adipocytes. The results showed that although FGFR-2 was expressed in both pre-adipocytes and adipocytes FGF-21 could only enable adipocyte-expressed FGFR-2 tyrosine phosphorylation, which was consistent with glucose-uptake by FGF-21 in this two cell types. FGF-21 not only phosphorylated in situ adipocyte-expressed FGFR-2, but also ectopically expressed FGFR-2 in mouse pre-B cell line BaF3 cells. Sequencing analysis of FGFR-2 cDNA from adipocytes revealed that FGFR-2 III c was the only subtype of FGFR-2 expressed in adipocytes, suggesting that FGFR-2 III c is at least one of the functional receptors for FGF-21 and involved in glucose metabolism in the cells. In order to understand the reason why the same FGFR-2 only functions in adipocyte and not in pre-adipocytes, differential expression of FGFR-2 before and after 3T3L1 cell differentiation was systematically analyzed, the result showed that adipocytes expressed high level precursors of FGFR-2, which were not observed in pre-adipocytes, suggesting FGFR-2 turn-over rate could be a key factor to determine the function the molecule. Alternatively, adipocyte-specific molecules could be another key factor participating the signal transduction of FGF-21.

Human Fibroblast Growth Factor-21 Regulates Glucose Uptake in 3T3-L1 Adipocytes

[Efficient Expression of Soluble Human FGF-21 and Its Glucose Regulation Activity].

Cloning, expression and glucose regulation activity of human FGF-21 HOU Yu-Ting, LI Jin-Nan, REN Gui-Ping, LIU Ming-Yao, SUN Guo-Peng, WANG Wen-Fei, LI De-Shan

Fibroblast Growth Factor 21 Improves Glucose Homeostasis Partially Via Down-Regulation of Na+-d-glucose Cotransporter SGLT1 in the Small Intestine.

Study on FGF-21 regulates glucose uptake in HepG2 cells

[Cloning, Expression and Glucose Regulation Activity of Human FGF-21].

Fibroblast Growth Factor Receptor-2 Involved In Fgf-21-Mediated Glucose Metabolism

Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism

FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction

The studies on hypoglycemic effect of rhFGF21 both in vitro and in vivo

[Expression and Pharmacological Evaluation of Fusion Protein FGF21-L-Fc].

Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.

FGF21 Suppresses Hepatic Glucose Production Through the Activation of Atypical Protein Kinase Cι/λ.

Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes*

Large-Scale Expression, Purification, and Glucose Uptake Activity of Recombinant Human Fgf21 in Escherichia Coli

Identification of Binding Partners of Fibroblast Growth Factor-21 in Cell Membrane of 3T3-L1 Cells

The Synergistic Effect of FGF-21 and Insulin on Regulating Glucose Metabolism and Its Mechanism

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells

Liver Plays a Major Role in FGF-21 Mediated Glucose Homeostasis.

Fibroblast Growth Factor 21 Increases Insulin Sensitivity Through Specific Expansion of Subcutaneous Fat

Stability and Glucose Regulation of FGF21 after Modified with Arginines*